Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User

Description

List of Tables

The Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is expected to reach US$ 1,911.95 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.

Increasing Number of Hyperpigmentation Disorder Awareness Programs Drives Europe Hyperpigmentation Disorder Treatment Market

Campaigns to raise awareness about UV-induced skin hyperpigmentation are essential to educate the general populace on the prevention, screening, diagnosis, and treatment of these conditions; they also discuss the importance of using good-quality sunscreen products to manage these disorders.

On May 25, 2022, Bella Aurora celebrated the International Skin Pigmentation Day. With over 130 years of experience in the research of skin pigmentation, Bella Aurora launched an international awareness campaign to celebrate the day with the support of renowned dermatologists, pharmacists, and key opinion leaders across the Spain and Italy. In June 2021, Dermalogica Clear launched a campaign to encourage skin acceptance and educate audiences on post-inflammatory hyperpigmentation, acne, breakouts, and more.

The increased awareness of melasma and other hyperpigmentation disorders has led to a surge in demand for innovative and efficacious treatment products and procedures. Moreover, it has brought about a significant and positive change in how society understands and manages hyperpigmentation. Thus, the increasing number of awareness programs bolsters the growth of the hyperpigmentation disorder treatment market.

Europe Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in Europe is segmented into Germany, UK, France, Italy, Spain, and Rest of Europe. The Germany held the largest Europe hyperpigmentation disorder treatment market share in 2023. Factors such as increasing awareness and emphasis on skincare and dermatological health among the population driving the market growth. Germans are increasingly proactive in seeking advanced skincare solutions to address hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation, driving the demand for innovative treatments in the market. Additionally, the rise in the aging population in Germany has led to numerous age-related skin concerns, including hyperpigmentation, prompting individuals to seek specialized treatments to maintain radiant skin. According to the Federal Statistical Office of Germany (Statistisches Bundesamt), the number of people aged 67 and above would increase from 4 million to at least 20 million by the mid-2030s. A culture that values skin care and anti-aging solutions, coupled with population aging and high skin disease prevalence, contributes to the demand for hyperpigmentation disorder treatments in Germany. Furthermore, rising attention and concerns about appearance continue to be a key factor in increasing the demand for various cosmetic procedures, contributing to strong market growth. Moreover, the presence of advanced medical infrastructure, skilled dermatologists, and reputable cosmetic clinics in Germany contributes to the accessibility of a wide range of hyperpigmentation treatments and procedures, attracting both domestic and international patients seeking quality skin care services.

Europe Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Hyperpigmentation Disorder Treatment Market Segmentation

The Europe hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.

Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.

Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.

By country, the Europe hyperpigmentation disorder treatment market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hyperpigmentation disorder treatment market share in 2022.

AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the Europe hyperpigmentation disorder treatment market.

Product Code: BMIRE00030847

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

4.1 Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Rise in Prevalence of Melasma
- 4.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.3 Market Restraints
- 4.3.1 High Cost of Treatments
4.4 Market Opportunities
- 4.4.1 Strategic Initiatives by Market Players
4.5 Future Trends
- 4.5.1 Use of Ablative Lasers
- 4.5.2 Novel Products Based on PATH-3 Technology
4.6 Impact of Drivers and Restraints:

5. Hyperpigmentation Disorder Treatment Market - Europe Analysis

5.1 Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030

6. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

6.1 Cosmeceutical
- 6.1.1 Overview
- 6.1.2 Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
- 6.2.1 Overview
- 6.2.2 Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
- 6.3.1 Overview
- 6.3.2 Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
- 6.4.1 Overview
- 6.4.2 Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
- 6.5.1 Overview
- 6.5.2 Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Condition

7.1 Melasma
- 7.1.1 Overview
- 7.1.2 Melasma: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
- 7.2.1 Overview
- 7.2.2 Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
- 7.3.1 Overview
- 7.3.2 Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Hyperpigmentation Disorder Treatment Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
- 8.2.1 Overview
- 8.2.2 Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Hyperpigmentation Disorder Treatment Market - Country Analysis

9.1 Europe Hyperpigmentation Disorder Treatment Market
- 9.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 Germany
  - 9.1.1.3 Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.4 UK
  - 9.1.1.5 UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.6 France
  - 9.1.1.7 France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.8 Italy
  - 9.1.1.9 Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.10 Spain
  - 9.1.1.11 Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.12 Rest of Europe
  - 9.1.1.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

10. Hyperpigmentation Disorder Treatment Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 AbbVie Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 EpiPharm AG
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Galderma SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Obagi Cosmeceuticals LLC
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Bayer AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Lutronic Co Ltd
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 L'OREAL S.A.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Pierre Fabre SA
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms